Project Description

Take me to report

Published: 2021
Geography: Global
Author: CB Insights

Testing new drugs is a slow and expensive process. AI has the potential to disrupt clinical trials — from patient recruitment to adherence monitoring and data collection — and Covid-19 has catalyzed its adoption.